Cartesian Therapeutics, Inc. (LS:A407YS) IPO

Cartesian Therapeutics, Inc.

IPO

Went public as SELECTA BIOSCIENCES INC. Priced at US$14.00 a share. Final prospectus filed on Jun 23, 2016.

Price
US$14.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$70 million
Listing
SELB on the Nasdaq Global Market
Underwriters
UBS Investment Bank, Stifel, Canaccord Genuity, Needham & Company · In the order on the cover
Shares delivered
On or about Jun 27, 2016

Steps

StepWhen
Draft sent to the SEC in confidenceNov 24, 2015
Filed publiclyMay 24, 2016
Amended twiceNewest Jun 20, 2016
Shares registered with an exchangeJun 8, 2016
Declared effective by the SECJun 21, 2016
Final prospectus, with the priceJun 23, 2016

From the cover of the final prospectus (424B4) filed Jun 23, 2016